PLC-β1 can regulate the phosphorylation of ERK and serine/threonine kinase (AKT), and then activate phosphoinositide-3 kinase (PI3K)/AKT signal to induce CCA cells to undergo EMT. This evidence concerns the gene AKT1 and cholangiocarcinoma.